Genetic control of sensitivity to hippocampal cell death induced by kainic acids: A quantitative trait loci analysis

Journal of Comparative Neurology

Volumn 477, Issue 1, 2004, Pages 96-107

  Schauwecker, Paula Elyse ^a   Williams, Robert W ^b   Santos, Julia Belen ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Epilepsy; Excitotoxicity; Mouse genetics; Quantitative trait loci; Seizure

Indexed keywords

EXCITOTOXIN; GENOMIC DNA; KAINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DENSITY; CELL STRUCTURE; CHROMOSOME 18; CONGENIC STRAIN; CONTROLLED STUDY; DOMINANT GENE; FEMALE; GENDER; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; HIPPOCAMPUS; HOST; INBRED STRAIN; MALE; MOUSE; NERVE CELL LESION; NERVE DEGENERATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SEIZURE; STRAIN DIFFERENCE;

ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; CELL DEATH; CHROMOSOME MAPPING; CROSSES, GENETIC; EXCITATORY AMINO ACID AGONISTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIPPOCAMPUS; HISTOCYTOCHEMISTRY; KAINIC ACID; LINKAGE (GENETICS); MALE; MICE; MICE, INBRED STRAINS; NERVE DEGENERATION; NEURONS; PHENOTYPE; QUANTITATIVE TRAIT LOCI; SEIZURES;

EID: 3843081736     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20245     Document Type: Article

References (69)

1. Akbar MT, Lundberg AM, Liu K, Vidyadaran S, Wells KE, Dolatshad H, Wynn S, Wells DJ, Latchman DS, de Belleroche J. 2003. The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J Biol Chem 278:19956-19965.
2. Ben-Ari Y. 1985. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14:375-403.
3. Ben-Ari Y, Cossart R. 2000. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci 23:580-587.
4. Bouilleret V, Ridoux V, Depaulis A, Marescaux C, Nehlig A, Le Gal La Salle G. 1999. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89:717-729.
5. Chen Z, Ljunggren HG, Bogdanovic N, Nennesmo I, Winblad B, Zhu J. 2002. Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice. Brain Res 931:135-145.
6. Churchill GA, Doerge RW. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138:963-971.
7. Coulter DA. 1999. Chronic epileptogenic cellular alterations in the limbic system after status epilepticus. Epilepsia 40:S23-S33.
8. Davenport CJ, Brown WJ, Babb TL. 1990. Sprouting of GABAergic and mossy fiber axons in dentate gyrus following intrahippocampal kainate in the rat. Exp Neurol 109:180-190.
9. Engel J Jr. 1996. Clinical evidence for the progressive nature of epilepsy. Epilepsy Res Suppl 12:9-20.
10. Ferrarese C, Tewmolizzo L, Rigoldi M, Sala G, Begni B, Brighina L, Ricci G, Alibizzati MG, Piolti R, Crosti F, Dalpra L, Frattola L. 2001. Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease. Neurol Sci 22:65-66.
11. Ferraro TN, Golden GT, Smith GG, Berrettini WH. 1995. Differential susceptibility to seizures induced by kainic acid. Epilepsia 36:301-307.
12. Ferraro TN, Golden GT, Smith GG, Schork NJ, St. Jean P, Ballas C, Choi H, Berrettini WH. 1997. Mapping murine loci for seizure response to kainic acid. Mamm Genome 8:200-208.
13. Ferraro TN, Golden GT, Snyder R, Laibinis M, Smith GG, Buono RJ, Berrettini WH. 1998. Genetic influences on electrical seizure threshold. Brain Res 813:207-210.
14. Ferraro TN, Golden GT, Smith GG, St. Jean P, Schork NJ, Mulholland N, Ballas C, Schill J, Buono RJ, Berrettini WH. 1999. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 19:6733-6739.
15. Ferraro TN, Golden GT, Smith GG, Longman RL, Snyder RL, DeMuth D, Szpilzak I, Mulholland N, Eng E, Lohoff FW, Buono RJ, Berrettini WH. 2001. Quantitative genetic study of maximal electroshock seizure threshold in mice: evidence for a major seizure susceptibility locus on distal chromosome 1. Genomics 75:35-42.
16. Franklin KBJ, Paxinos G. 1997. The mouse brain in stereotaxic coordinates. New York: Academic Press.
17. Fujikawa DG. 1995. The neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 36:186-195.
18. Fujikawa DG. 1996. The temporal evolution of neuronal damage from pilocarpine-induced status epilepticus. Brain Res 725:11-22.
19. Fujikawa DG, Daniels AH, Kim JS. 1994. The competitive NMDA-receptor antagonist CGP 40116 protects against status epilepticus-induced neuronal damage. Epilepsy Res 17:207-219.
20. Gorter JA, van Vliet EA, Aronica E, Lopes da Silva FH. 2001. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss ofhilar parvalbumin and somatostatin-immunoreactive neurons. Eur J Neurosci 13:657-669.
21. Green PS, Simpkins JW. 2000. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 18:347-358.
22. Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP. 1999. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5:101-106.
23. Haberman RP, Samulski RJ, McCown TJ. 2003. Attenuation of seizures and neuronal death by adeno-associated virus vector galanin expression and secretion. Nat Med 9:1076-1080.
24. Heber S, Herms J, Gajie V, Hainfellner J, Aguzzi A, Rulicke T, von Kretzschmar H, von Koch C, Sisodia S, Tremml P, Lipp HP, Wolfer DP, Muller U. 2000. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 20:7951-7963.
25. Houser CR. 1999. Neuronal loss and synaptic reorganization in temporal lobe epilepsy. Adv Neurol 79:743-761.
26. Hu RQ, Koh S, Torgerson T, Cole AJ. 1998. Neuronal stress and injury in C57/BL mice after systemic kainic acid administration. Brain Res 810:229-240.
27. Iadecola C, Sugimoto K, Niwa K, Kazama K, Ross ME. 2001. Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice. J Cereb Blood Flow Metab 21:1436-1441.
28. Jacoby AS, Hort YJ, Constantinescu G, Shine J, Iismaa TP. 2002. Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity. Brain Res Mol Brain Res 107:195-200.
29. Joels M, Karten Y, Hesen W, de Kloet ER. 1997. Corticosteroid effects on electrical properties of brain cells: temporal aspects and role of anti-glucocorticoids. Psychoneuroendocrinology 22:S81-S86.
30. Kelly ME, McIntyre DC. 1994. Hippocampal kindling protects several structures from neuronal damage resulting for kainic acid-induced status epilepticus. Brain Res 634:245-256.
31. Knott SA, Haley CS. 1992. Maximum likelihood mapping of quantitative trait loci using full-sib families. Genetics 132:1211-1222.
32. Kondratyev A, Sahibzada N, Gale K. 2001. Electroconvulsive shock exposure prevents neuronal apoptosis after kainic acid-evoked status epilepticus. Brain Res Mol Brain Res 91:1-13.
33. Lander E, Kruglyak L. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247.
34. Lothman EW, Bertram EH. 1993. Epileptogenic effects of status epilepticus. Epilepsia 34:S59-S70.
35. Lowenstein DH. 1996. Recent advances related to basic mechanisms of epileptogenesis. Epilepsy Res Suppl 11:45-60.
36. Maltais LJ, Blake JA, Eppig JT, Davisson MT. 1997. Rules and guidelines for mouse gene nomenclature: a condensed version. International Committee on Standardized Genetic Nomenclature for Mice. Genomics 45:471-476.
37. Manly KF, Cudmore RH Jr, Meer JH. 2001. Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome 12:930-932.
38. Marco S, Canudas AM, Canals JM, Gavalda N, Perez-Navarro E, Alberch J. 2002. Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum. Exp Neurol 174:243-252.
39. Mathern GW, Cifuentes F, Leite JP, Pretorius JK, Babb TL. 1993. Hippocampal EEG excitability and chronic spontaneous seizures are associated with aberrant synaptic reorganization in the rat intrahippocampal kainate model. Electroencephalogr Clin Neurophysiol 87:326-339.
40. Mazarati AM, Halaszi E, Telegdy G. 1992. Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res 589:164-166.
41. Mazarati AM, Liu H, Soomets U, Sankar R, Shin D, Katsumori H, Langel U, Wasterlain CG. 1998. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. Neurosci 18:10070-10077.
42. Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA, Wynick D, Wasterlain CG. 2000. Modulation of hippocampal excitability and seizures by galanin. J Neurosci 20:6276-6281.
43. Mirjany M, Ho L, Pasinetti GM. 2002. Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotexicity. J Pharmacol Exp Ther 301:494-500.
44. Morrison RS, Wenzel HJ, Konoshita Y, Robbins CA, Donehower LA, Schwartzkroin PA. 1996. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J Neurosci 16:1337-1345.
45. Nadler JV. 1981. Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 29:2031-2042.
46. Nadler JV, Evenson DA. 1983. Use of excitatory amino acids to make axon-sparing lesions of hypothalamus. Methods Enzymol 103:393-400.
47. Nadler JV, Perry BW, Cotman CW. 1978. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells. Nature 271:676-677.
48. Neuhaus IM, Sommardahl CS, Johnson DK, Beier DR. 1997. Microsatellite DNA variants between the FVB/N and C3HeB/FeJLe and C57BIJ6J mouse strains. Mamm Genome 8:506-509.
49. Nitecka L, Tremblay E, Charton G, Bouillot JP, Berger ML, Ben-Ari Y. 1984. Maturation of kainic acid seizure-brain damage syndrome in the rat. II. Histopathological sequelae. Neuroscience 13:1073-1094.
50. Olney JW, Collins RC, Sloviter RS. 1986. Excitotoxic mechanisms of epileptic brain damage. Adv Neurol 44:857-877.
51. O'Meara G, Coumis U, Ma SY, Kehr J, Mahoney S, Bacon A, Allen SJ, Holmes F, Kahl U, Wang FH, Kearns IR, Ove-Ogren S, Dawbarn D, Mufson EJ, Davies C, Dawson G, Wynick D. 2000. Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci U S A 97:11569-11574.
52. Racine RJ. 1972. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294.
53. Schauwecker PE. 2000. Seizure-induced neuronal death is associated with induction of c-Jun N-terminal kinase and is dependent on genetic background. Brain Res 884:116-128.
54. Schauwecker PE. 2003a. Genetic basis of kainate-induced excitotoxicity in mice: phenotypic modulation of seizure-induced cell death. Epilepsy Res 55:201-210.
55. Schauwecker PE, Steward O. 1997. Genetic determinants of susceptibility to excitotoxic cell death: implications for gene targeting approaches. Proc Natl Acad Sci U S A 94:4103-4108.
56. Schmued LC, Hopkins KJ. 2000. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874: 123-130.
57. Sidman RL, Angevine JB, Taber Pierce E. 1971. Atlas of the mouse brain and spinal cord. Cambridge, MA: Harvard University Press.
58. Sperk G. 1994. Kainic acid seizures in the rat. Prog Neurobiol 42:1-32.
59. Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, Hornykiewicz O. 1983. Neurochemical and histopathological changes. Neuroscience 10: 1301-1315.
60. Sutula TP. 1990. Experimental models of temporal lobe epilepsy: new insights from the study of kindling and synaptic reorganization. Epilepsia 31(Suppl 3):S45-S54.
61. Todorova MT, Burwell TJ, Seyfried TN. 1999. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 40:1697-1707.
62. Todorova M, Tandon P, Madore RA, Stafstrom CE, Seyfried TN. 2000. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 41:933-940.
63. Wakana S, Sugaya E, Naramoto F, Yokote N, Maruyama C, Jin W, Ohguchi H, Tsuda T, Sugaya A, Kajiwara K. 2000. Gene mapping of SEZ group genes and determinism of pentylenetetrazol susceptible quantitative trait loci in the mouse chromosome. Brain Res 857:286-290.
64. Wasterlain CG, Fujikawa DG, Penix L, Sankar R. 1993. Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 34: S37-S53.
65. Watanabe Y, Johnson RS, Butler LS, Binder DK, Spiegelman BM, Papaioannou VE, McNamara JO. 1996. Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy. J Neurosci 16:3827-3836.
66. Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Pakic P, Flavell RA. 1997. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389:865-870.
67. Young D, Lawlor PA, Leone P, Dragunow M, During MJ. 1999. Environmental enrichment inhibits spontaneous apoptosis, prevents seizures and is neuroprotective. Nat Med 5:448-453.
68. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, Hayden MR, Raymond LA. 2002. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 33:849-860.
69. Zini S, Roisin M-P, Langel Ü, Bartfai T, Ben-Ari Y. 1993. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur J Pharmacol 245:1-7.